Effects of pioglitazone and rosiglitazone on interferon-γ, tumor necrosis factor-α, interleukin-1β, interleukin-4, interleukin-6 and C-reactive protein in diabetic patients.

被引：0

作者：

Tan, SA ^{[1
]}

Tan, LG ^{[1
]}

Berk, LS ^{[1
]}

机构：

[1] Oakcrest Hlth Res Inst, Greenville, SC USA

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 2002年 / 42卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

下载

页码：1060 / 1060

页数：1

共 50 条

[1] Effects of pioglitazone and rosiglitazone on interferon-γ, tumor necrosis factor-α, interleukin-1β, interleukin-4, interleukin-6 and C-reactive protein in diabetic patients with atherosclerosis
Tan, SA
Tan, LG
Berk, LS
Lukman, LF
22ND MEETING OF THE EUROPEAN SOCIETY FOR MICROCIRCULATION: MICROCIRCULATION AND VASCULAR BIOLOGY, 2002, : 83 - 87
[2] Comparative study of the effects of rosiglitazone and pioglitazone on interferon-γ, Tumor Necrosis Factor, Interleukin-1β, Interleukin-4, Interleukin-6 and C-reactive protein in diabetic patients with atherosclerosis
Tan, SA
Tan, LG
Berk, LS
DIABETES, 2002, 51 : A595 - A595
[3] Synergistic modulating effects of ramipril and rosiglitazone on interferon-γ, tumor nerosis factor-α, interleukin-6, interleukin-4, and C-reactive protein in diabetic patients
Tan, S
Tan, L
Berk, L
Lukman, L
DIABETES, 2003, 52 : A477 - A478
[4] Pravastatin and rosiglitazone may attenuate coronary artery disease by decreasing interferon-γ, tumor necrosis factor-α, interleukin-6, macrophage chemotactic protein-1, C-reactive protein, and increasing interleukin-4
Tan, L. G.
Tan, S. A.
Berk, L. S.
NEW HORIZONS IN CORONARY ARTERY DISEASE, 2007, : 175 - 179
[5] Atorvastatin affects Th-1 and rosiglitazone Th-2 cytokines, and the synergistic effects of combined atorvastatin and rosiglitazone on attenuating interferon-γ, tumor necrosis factor-α and interleukin-6, and stimulating interleukin-4, resulting in lowering C-reactive protein in diabetic patients with hyperlipidemia
Tan, S
Tan, L
Shirolkar, S
PROCEEDINGS OF THE 12TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY, 2004, : 741 - 745
[6] Complement factor I is upregulated in rat hepatocytes by interleukin-6 but not by interferon-γ, interleukin-1β or tumor necrosis factor-α
Schlaf, G
Demberg, T
Koleva, M
Jungermann, K
Götze, O
BIOLOGICAL CHEMISTRY, 2001, 382 (07) : 1089 - 1094
[7] Combined effects of rosuvastatin and pioglitazone in attenuating interferon gamma, tumor necrosis factor alpha, interleukin-6, C-reactive protein, and increasing interleukin-4 may provide cardioprotection for patients with diabetes
Tan, Linda G.
Berk, Lee S.
Tan, Stanley A.
CHEST, 2006, 130 (04) : 191S - 191S
[8] Combined effects of ramipril and carvedilol on attenuating interferon-γ, tumor necrosis factor-α, interleukin-6 and C-reactive protein, and improving heart failure in diabetic patients
Tan, S
Tan, L
Berk, L
Lukman, L
FRONTIERS IN CORONARY ARTERY DISEASE, 2003, : 409 - 413
[9] Complement factor I is upregulated in rat hepatocytes and HUVEC by interleukin-6 but not by interferon-γ, interleukin-1β or tumor necrosis factor-α
Demberg, T
Schlaf, G
Götze, O
MOLECULAR IMMUNOLOGY, 2001, 38 (2-3) : 84 - 85
[10] Swertia chirayita mediated modulation of interleukin-1β interleukin-6, interleukin-10, interferon-γ, and tumor necrosis factor-α in arthritic mice
Kumar, IVMLRS
Paul, BN
Asthana, R
Saxena, A
Mehrotra, S
Rajan, G
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2003, 25 (04) : 573 - 583

← 1 2 3 4 5 →